Glaxo HIV drug wins US approval
Glaxo Wellcome won US regulatory approval for Agenerase, an HIV drug that will bolster the UK pharmaceutical company's leadership in the antiretroviral market. Agenerase is a protease inhibitor, one
Glaxo Wellcome won US regulatory approval for Agenerase, an HIV drug that will bolster the UK pharmaceutical company's leadership in the antiretroviral market. Agenerase is a protease inhibitor, one